SEC Form 4 · accession 0001140361-17-031028
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Atul Saran
Officer — EVP, Corp Dev, GC & Secretary
Period of report
Aug 8, 2017
Accepted (ET)
Aug 10, 2017 · 1:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 8, 2017 | A | 12,814 | $0.00 | A | 12,814 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F3 | $36.09 | Aug 8, 2017 | A | 20,083 | A | — | Aug 7, 2024 | Common Stock | 20,083 | 20,083 | D |
Explanation of responses
- F1Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
- F2These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- F3Vests in three equal installments on August 7, 2018, August 7, 2019 and August 7, 2020.
Remarks
Exhibit List: Ex 24.1 - Power of Attorney